补肾益气化瘀解毒汤抗肝纤维化的临床观察

Clinical Observation of Bushen Yiqi Huayu Jiedu Decoction in the Treatment of Hepatic Fibrosis

  • 摘要: 目的 观察补肾益气化瘀解毒汤抗肝纤维化作用。方法 临床选择98例肝纤维化患者,随机分为2组各49例,对照组口服鳖甲软肝片,治疗组服用补肾益气化瘀解毒汤,治疗6月后观测其临床疗效、中医证候积分、肝肾功能、肝纤维化指标、肝脾B超等指标的变化。结果 治疗后,治疗组总有效率明显高于对照组(P<0.01);2组中医证候积分,均明显下降(P<0.05~0.01),治疗组优于对照组(P<0.01)。治疗组谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TBIL)、白蛋白(ALB)含量明显下降(P<0.01),明显优于对照组(P<0.01);治疗组透明质酸(HA)、Ⅳ型胶原(Ⅳ-C)、Ⅲ型前胶原(PCⅢ)水平明显下降(P<0.01),明显优于对照组(P<0.01)。治疗组门静脉、脾静脉内径及脾脏厚度明显缩小(P<0.05~0.01),明显优于对照组(P<0.01);治疗组肝脏硬度值明显下降,优于对照组(P<0.01)。结论 补肾益气化瘀解毒汤抗肝纤维化效果确切。

     

    Abstract: OBJECTIVE To observe the effect of Bushen Yiqi Huayu Jiedu Decoction on anti-hepatic fibrosis. METHODS 98 patients with hepatic fibrosis were randomly divided into two groups, 49 in each group. The control group was given Biejia Ruangan Tablet. The treatment group was given Bushen Yiqi Huayu Jiedu Decoction. After six months of treatment, the changes of clinical efficacy, TCM syndrome score, liver and kidney function, liver fibrosis index, liver and spleen B ultrasound were observed. RESULTS After treatment, the total effective rate of the treatment group was significantly higher than that of the control group (P<0.01); TCM syndrome scores in the two groups were significantly decreased (P<0.05, P<0.01), and the treatment group was better than that of the control group (P<0.01). The contents of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), albumin (ALB) in the treatment group decreased significantly (P<0.01), which was more obvious than that in the control group (P<0.01). The levels of hyaluronic acid (HA), collagen Ⅳ(Ⅳ-C), procollagen Ⅲ(PCⅢ) in the treatment group decreased significantly (P<0.01), which was better than that in the control group (P<0.01), the diameters of portal vein, splenic vein and the thickness of spleen in the treatment group decreased significantly (P<0.05, P<0.01), which was significantly better than that of the control group (P<0.01). After treatment, the B-ultrasound grade of the two groups decreased significantly (P<0.01). The liver hardness value of the treatment group was significantly lower than that of the control group(P<0.05). CONCLUSION Bushen Yiqi Huayu Jiedu Decoction shows definite anti-hepatic fibrosis effect.

     

/

返回文章
返回